地夫可特(Deflazacort)全网公布的2024年的最新价格

Introduction: Deflazacort is a corticosteroid used to treat Duchenne muscular dystrophy. Deflazacort delays the onset of muscle-related complications caused by Duchenne muscular dystrophy, extending the lives of children with the disease and having less harmful effects on bone health and weight than other steroid drugs.

The latest price of Deflazacort in 2024 published on the entire Internet

Currently, the prices of two versions are known and are for patients’ reference only.

1. German version: The specification of the German version of deflazacort is 6mg*100 tablets per box. The current price is about 600$-900$ per box.

2. Indian version: The specification of the Indian version of Deflazacort is 100 tablets per box, and the current price is about 300$-700$ per box.

The above price information is for reference only and may vary depending on factors such as region, supplier, purchasing channel, drug version, etc. When purchasing, it is recommended to consult a professional medical institution or drug supplier to obtain the most accurate price information, as well as learn about adverse drug reactions, precautions and other information.

Adverse reactions of Deflazacort

Deflazacort has risks common to all corticosteroids, including immunosuppression, reduced bone density, steroid-induced muscle atrophy, myopathy and endocrine insufficiency. In clinical trials, the most common side effects were Cushingoid appearance, weight gain, and increased appetite. If you develop an allergic reaction, such as hives, trouble breathing, swelling of the face or throat, or a severe skin reaction, such as sore skin, red or purple rash that blisters and flakes, you need immediate medical attention.

Usage and dosage of Deflazacort

According to the drug instructions, the recommended dose for adults and children aged 2 years and above is 0.9 mg/kg/day, and the medication needs to be based on the patient's weight. Safety and effectiveness have not been established for children under 2 years of age, and the drug is not recommended for children in this age group. If tablets are used, round to the nearest dose and any combination of tablet strengths may be used to achieve the calculated dose. If oral suspension is used, round to the nearest 1/10 milliliter (mL).

If deflazacort is co-administered with a CYP3A4 inhibitor, such as a moderate or strong CYP3A4 inhibitor, 1/3 of the recommended deflazacort dose should be administered.